Patent Assignment
Reel/Frame 049274/0983
Nunc Pro Tunc Assignment
Recorded: 2019-05-24
Pages: 4
Assignor
MALLINCKRODT IP UNLIMITED COMPANY
Executed: 2019-05-24
Assignee
MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
COLLEGE BUSINESS & TECHNOLOGY PARK, CRUISERATH, BLANCHARDSTOWN, DUBLIN, 15, IRELAND
Covered Properties
(18)
Preparation of Metal Mesoporphyrin Halide Compounds
Preparation of Metal Mesoporphyrin Compounds
High-Purity Large-Scale Preparation of Stannsoporfin
Preparation of Metal Mesoporphyrin Compounds
Preparation of Metal Mesoporphyrin Compounds
High-Purity Large-Scale Preparation of Stannsoporfin
Methods for Synthesizing Metal Mesoporphyrins
Methods for Treating Hyperbilirubinemia with Stannsoporfin
Application:
13/691,677 →
Publication:
US 2013/0158362
High-Purity Large-Scale Preparation of Stannsoporfin
Methods for Synthesizing Metal Mesoporphyrins
High-Purity Large-Scale Preparation of Stannsoporfin
High-Purity Large-Scale Preparation of Stannsoporfin
Methods for Synthesizing Metal Mesoporphyrins
High-Purity Large-Scale Preparation of Stannsoporfin
High-Purity Large-Scale Preparation of Stannsoporfin
Methods for Synthesizing Metal Mesoporphyrins
High-Purity Large-Scale Preparation of Stannsoporfin
Methods For Treating Hyperbilirubinemia With Stannsoporfin And Phototherapy
Application:
16/300,362 →
Publication:
US 2020/0001109
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 6, 2016
From: DRUMMOND, GEORGE S.; CAROSELLI, ROBERT; COOKE, KEITH A.; LEVIN, DANIEL
To: INFACARE PHARMACEUTICAL CORPORATION
Reel/Frame 040831/0919 →
Assignment of Assignor's Interest
Jul 14, 2018
From: DRUMMOND, GEORGE S.; CAROSELLI, ROBERT; COOKE, KEITH A.; LEVIN, DANIEL
To: INFACARE PHARMACEUTICAL CORPORATION
Reel/Frame 046545/0148 →
Assignment of Assignor's Interest
Oct 4, 2018
From: BOUCHER, CHRISTOPHER P; ROE, DAVID
To: INFACARE PHARMACEUTICAL CORPORATION
Reel/Frame 047072/0681 →
Assignment of Assignor's Interest
Apr 1, 2019
From: DRUMMOND, GEORGE S.; CAROSELLI, ROBERT; COOKE, KEITH A.; LEVIN, DANIEL
To: INFACARE PHARMACEUTICAL CORPORATION
Reel/Frame 048757/0308 →
Nunc Pro Tunc Assignment
May 24, 2019
From: MALLINCKRODT PHARMA IP TRADING D.A.C.
To: MALLINCKRODT IP UNLIMITED COMPANY
Reel/Frame 049274/0954 →
Nunc Pro Tunc Assignment
May 24, 2019
From: INFACARE PHARMACEUTICAL CORPORATION
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 049274/0943 →
Notice of Grant of Security Interest in Intellectual Property
Jul 22, 2019
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 049822/0674 →
Security Interest
Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Security Interest
Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Release of Security Interest
Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Notice of Grant of Security Interest in Intellectual Property
Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Security Interest
Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Security Interests in Patents at Reel 060389/Frame 0913
Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Release of Patent Security Interests Recorded at Reel 044173, Frame 0574
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0128 →
Release of Patent Security Interests Recorded at Reel 049822, Frame 0674
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065609/0454 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →
Release of Security Interest
Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 072324/0740 →